DIMILL COLLIRIA 10ML 0.01%

DI MILL 0.1 MG/ML COLLIRIO, DEOLUTION

active ingredients

1 ml contains: Benzalconio chloride 0.1 mg. For the full list of excipients, see paragraph 6.1

Excellent

Sodium chloride; Sterile distilled water Matricaria Chamomilla and Hamamelis Virginiana; Purified water.

Therapeutic indications

For the disinfection of the eye also irritated by dust, smoke and smog.

Contraindications

• Hypersensitivity to the active ingredient or any of the excipients listed in paragraph 6.1. • Do not use in children under 12 years.

Population

Posology Instill two drops of product in each eye, two or three times a day. DON'T OVERDO IT.

Conservation

This medicine does not require any special condition of conservation.

Warnings

Do not use for prolonged treatments; after short period of treatment without appreciable results consult your doctor. The ingestion or accidental inhalation of some disinfectants may have serious, sometimes fatal consequences (see paragraph 4.9). In case of accidental product ingestion, consult a doctor immediately. Avoid the tip of the dropper coming in contact with the eyes. The benzalconio chloride can cause irritation to the eyes. Avoid contact with soft contact lenses. Remove contact lenses before application and wait at least 15 minutes before reapplying them. It is known the decoloring action against soft contact lenses. Do not use when wearing contact lenses. The product is only for external use. It is to avoid the application in case of inflammation, wounds or corneal abrasions. Prolonged use of topical products can give rise to awareness-raising phenomena, in this case interrupt treatment and consult your doctor to establish suitable therapy. DI MILL contains benzalconio chloride. There are no differences in the profile of adverse events in children compared to adults. Cases of eye irritation, dry eye, alteration of film and corneal surface were reported as a result of ophthalmic administration of benzalconio chloride. To be used with caution in patients with dry eye and with impairment of cornea. Patients should be monitored in case of prolonged use.

Interactions

Avoid the contemporary use of other antiseptics and detergents (anionic, soap, citrates, ioduri, nitrates, permanganates, tartrates, salicylates and silver salts).

Effects

In some cases, intolerance (burning or irritation) may occur, however, without consequences, which does not require modification of treatment. Reporting of suspicious adverse reactions The reporting of suspicious adverse reactions occurring after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at: https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.

Overdosing

No overdose damage has been reported under normal conditions. Accidental ingestion can cause nausea and vomiting. Symptoms of intoxication resulting in ingestion of significant amounts of quaternary ammonia compounds include dispnea, cyanosis, asphyxiation resulting from paralysis of respiratory muscles, SNC depression, hypotension and coma. In man the lethal dose is 1-3 g. The treatment of poisoning is symptomatic: administer if necessary lenitives. Avoid emesis and gastric lavender.

It's not contraindicated.

Source: Farmadati